Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.
OBJECTIVE
The transient middle cerebral artery occlusion (MCAO) model of stroke is one of the most commonly used models to study focal cerebral ischemia. This procedure also results in the simultaneous occlusion of the ophthalmic artery that supplies the retina. Retinal cell death is seen days after reperfusion and leads to functional deficits; however, the mechanism responsible for this injury has not been investigated. Given that the eye may have a unique ocular immune response to an ischemic challenge, this study examined the inflammatory response to retinal ischemia in the MCAO model.


METHODS
Young male C57B/6 mice were subjected to 90-min transient MCAO and were euthanized at several time points up to 7 days. Transcription of inflammatory cytokines was measured with quantitative real-time PCR, and immune cell activation (e.g., phagocytosis) and migration were assessed with ophthalmoscopy and flow cytometry.


RESULTS
Observation of the affected eye revealed symptoms consistent with Horner's syndrome. Light ophthalmoscopy confirmed the reduced blood flow of the retinal arteries during occlusion. CX3CR1-GFP reporter mice were then employed to evaluate the extent of the ocular microglia and monocyte activation. A significant increase in green fluorescent protein (GFP)-positive macrophages was seen throughout the ischemic area compared to the sham and contralateral control eyes. RT-PCR revealed enhanced expression of the monocyte chemotactic molecule CCL2 early after reperfusion followed by a delayed increase in the proinflammatory cytokine TNF-α. Further analysis of peripheral leukocyte recruitment by flow cytometry determined that monocytes and neutrophils were the predominant immune cells to infiltrate at 72 h. A transient reduction in retinal microglia numbers was also observed, demonstrating the ischemic sensitivity of these cells. Blood-eye barrier permeability to small and large tracer molecules was increased by 72 h. Retinal microglia exhibited enhanced phagocytic activity following MCAO; however, infiltrating myeloid cells were significantly more efficient at phagocytizing material at all time points. Immune homeostasis in the affected eye was largely restored by 7 days.


CONCLUSIONS
This work demonstrates that there is a robust inflammatory response in the eye following MCAO, which may contribute to a worsening of retinal injury and visual impairment. These results mirror what has been observed in the brain after MCAO, suggesting a conserved inflammatory signaling response to ischemia in the central nervous system. Imaging of the eye may therefore serve as a useful non-invasive prognostic indicator of brain injury after MCAO. Future studies are needed to determine whether this inflammatory response is a potential target for therapeutic manipulation in retinal ischemia.
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Rodney M
RM
Ritzel
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Sarah J
SJ
Pan
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Rajkumar
R
Verma
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
John
J
Wizeman
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Joshua
J
Crapser
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Anita R
AR
Patel
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Richard
R
Lieberman
Neuroscience Department, University of Connecticut Health Center, Farmington, CT.
Royce
R
Mohan
Neurology Department, University of Texas Health Science Center at Houston, Houston, TX.
Louise D
LD
McCullough
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000235:genetics / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism*; D001813:Blood-Retinal Barrier / Q000502:physiology; D002199:Capillary Permeability / Q000502:physiology; D016207:Cytokines / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D005434:Flow Cytometry; D020244:Infarction, Middle Cerebral Artery / Q000235:genetics / Q000378:metabolism*; D018836:Inflammation Mediators / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009880:Ophthalmic Artery / Q000378:metabolism*; D010587:Phagocytosis / Q000502:physiology; D060888:Real-Time Polymerase Chain Reaction; D020521:Stroke / Q000235:genetics / Q000378:metabolism*
D015415:Biomarkers; D016207:Cytokines; D018836:Inflammation Mediators